News from Zyme and the companies we work with.
SLAS Celebrates Innovative New Products, Startups and Scientific Excellence at European Conference in Vienna
SLAS Celebrates Innovative New Products, Startups and Scientific Excellence at European Conference in Vienna Vienna, Austria, 26 May 2026: SLAS, the Society of Laboratory Automation and Screening, after a six-year [...]
Tecan establishes direct sales and specialist lab automation service operations in India
Strengthening local presence and customer support in a high-growth life sciences market Männedorf, Switzerland, May 26, 2026:Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today [...]
OutSee selected for Discovery Award from Longitude Prize on ALS to accelerate AI-based target discovery
Funding to identify novel targets for ALS treatment using OutSee’s ‘genomics first’ target discovery platform, Nomaly Provides access to world’s largest and most comprehensive ALS patient dataset Part of £7.5M [...]
Cyclana Bio granted Health Research Authority approval and recruits first patients for clinical observational study in endometriosis
UK NHS grants HRA/REC approval for PEMP study with Peterborough and Cambridge hospitals Clinical observational study investigating underlying biology of endometriosis aims to uncover causal mechanisms and new druggable targets [...]
Qureight to support Mediar Therapeutics’ Phase 2 trial of MTX-474 in diffuse cutaneous Systemic Sclerosis
Qureight’s AI-powered quantitative imaging analytics platform and services to analyse HRCT images to evaluate changes in compartment-specific lung biomarkers The focus of these efforts will be on the quantitative assessment [...]
Enterprise Therapeutics achieves primary efficacy outcome in Phase 2 clinical trial for cystic fibrosis with novel inhaled ENaC blocker ETD001
First investigational inhaled ENaC blocker to deliver clinically relevant and statistically significant change in lung function compared to placebo Inhaled therapeutic designed to treat the 10% of people with cystic [...]
Nuclera launches antibody triage service to advance AI-driven antibody discovery
Rapid binder triage, of AI-driven candidate sets, enables early elimination of non-binders ahead of costly downstream workflows Powered by cell-free technology to convert AI-generated candidates into experimental binding data Cambridge, [...]
Calla Lily Clinical Care doses first patients in clinical trial for intravaginal drug delivery platform for threatened miscarriage
FREEDOM study to evaluate progesterone delivery using Callavid intravaginal platform NIHR-funded trial in collaboration with University Hospitals Coventry and Warwickshire NHS Trust London, UK, 06 May 2026: Calla Lily Clinical [...]
FUJIFILM Biosciences and NextCell Launch New Commercial Platform Comprised of RUO Stromal Cells and Cell Culture Media
Collaboration results in platform to help researchers overcome challenges in MSC research NextCell-Cord RUO cells designed for delivery as cryopreserved and sold as an individual product or bundled with PRIME-XV [...]
Bio-Rad Expands Range of TrailBlazer Kits for Antibody Conjugation to StarBright Dyes
Expanded Range Increases Access to Bio-Rad’s StarBright™ Dyes for Flow Cytometry and Western Blot Applications in Immunology Research HERCULES, Calif.—May 05, 2025—Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global [...]
Qureight establishes Scientific Advisory Board focused on pulmonary hypertension
Global industry experts in pulmonary diseases appointed: Marc Humbert, Steven Nathan, Oksana Shlobin, Vincent Cottin, Ardeschir Ghofrani, Joanna Pepke-Zaba and Luke Howard SAB will provide strategic and scientific perspectives to [...]
Lab Thread introduces Unified Lab Software Platform to streamline biological research
Connects scientific teams, data and workflows within a single, fully integrated digital lab management system Silverstone, UK, 30 April 2026: Lab Thread Ltd, a UK-based life science software company, today [...]
